Cardiology | Hemodynamics | Pressure-Volume Loops | Tricuspid Regurgitation | Zentrum für Kardiologie der Universitätsmedizin Mainz
Joined September 2020
- Tweets120
- Following243
- Followers199
- Likes746
Sebastian Rosch retweeted
World Premiere: first commercially approved transseptal mitral valve at Universitätsmedizin Mainz - the SAPIEN M3 TMVR - many more patients in the future. 🚀#PCR Mitral Focus Group
@vonBardelebenRS @AGIKinterv @DGK_org @EZancanaroMD @KardiologieHH @ESC_Journals @thiele_holger
Sebastian Rosch retweeted
Tolle Vorträge aus Mainz bei der Young-Investigator-Award Session zum Thema Herzinsuffizienz 🫀 @KP_Kresoja @RoschSeb @felix_mller @YoungDgk @DGK_org
Sebastian Rosch retweeted
Very dramatic case of dry tamponade: terrible complication
sciencedirect.com/science/ar…
@TobiasKister @thiele_holger
Sebastian Rosch retweeted
T-TEER improves 1-year survival in patients with intermediate-stage tricuspid regurgitation💡 No benefit seen in early or advanced stages 🚑 Timing of intervention is crucial for optimal outcomes! 🫀 jacc.org/doi/10.1016/j.jcin.…
#TEER #Cardiology #vhdTR @PhilippLurz
Sebastian Rosch retweeted
🔥 #THT2025 is in full swing! The room is packed with attendees diving into the latest breakthroughs in #heartfailure research and treatments. Exciting sessions, cutting-edge insights — this is where #innovation happens! 🫀🚀
#CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMD @javedbutler1 @djc795 @preventfailure @akshaydesaimd @JerryEstepMD @FudimMarat @UlrichJordeMD @manreetkanwar @navinkapur4 @dranulala @MartyBLeon @LindenfeldJoann @PopmaJeffrey @SMarxLab @gtsayer @WilsonTangMD @NirUrielMD @jgranadacrf @triciarawh @TCTConference @ISHLT @HFSA
Sebastian Rosch retweeted
Enjoying a great day hosting #FITs from @DGK_org at @hopkinsheart as part of @ACCMaryland exchange program. We have much to learn from each other in advancing cardiac care! @sxz110 @HadleyWilsonMD @CathieBiga @ACCinTouch
Sebastian Rosch retweeted
Wonderful to celebrate the 15th anniversary of MACCS in DC and welcome our first contingent of German cardiology fellows for @DGK_org - @ACCMaryland exchange! Main event tomorrow! @ACCinTouch @HadleyWilsonMD @CathieBiga @sxz110
Sebastian Rosch retweeted
supranormal ejection fraction HFpEF different entity with distinct pathophysiology and afterload and systolic stiffness/hypercontractility as disease drivers rather than fibrosis, just at the beginning here…
🔥#FINEARTS a win for #HFpEF
- Reduction in HFH 🏨 and trend for ☠️ ⬇️
- Yet again, no signal in HFpEF&LVEF >60%
- what's the deal with those ef>60% and high NT-proBNP level guys anyway?
@PhilippLurz @thiele_holger @vonBardelebenRS @KardiologieHH @MarcoMetra @kp_rommel #ESC2024
Sebastian Rosch retweeted
🔥#FINEARTS a win for #HFpEF
- Reduction in HFH 🏨 and trend for ☠️ ⬇️
- Yet again, no signal in HFpEF&LVEF >60%
- what's the deal with those ef>60% and high NT-proBNP level guys anyway?
@PhilippLurz @thiele_holger @vonBardelebenRS @KardiologieHH @MarcoMetra @kp_rommel #ESC2024
Sebastian Rosch retweeted
Finerenone meets primary endpoint in Phase III FINEARTS-HF🎉
❤️ expanded treatment options for HFpEF! —> to be presented at ESC
‼️pending: the SPIRRT HFPEF trial with MRA
@DCRINews @karolinskainst @UU_University @nih_nhlbi bayer.com/media/en-us/finere…
Sebastian Rosch retweeted
Why does treating #TR improve dyspnoea? Find out more on the importance and effects of #TTEER on left 🫀 #hemodynamics and #HeartFailure
onlinelibrary.wiley.com/doi/…
@kp_rommel @PhilippLurz @thiele_holger @A_Schoeber @RoschSeb @PSullivan000 @MarcoMetra @FH_Verbrugge
a 🧵1/6
Sebastian Rosch retweeted
Alles rund um HFpEF - spannende Sitzung des Tagunspräsidenten mit @PhilippLurz bei der #DGK2024JT @kp_rommel @KP_Kresoja @RoschSeb @DGK_org @youngdgk @docduc88 @docrogmarc @felix_mller @PhilipWenzel_76
Sebastian Rosch retweeted
Worldwide first commercial #EVOQUE case today at @unimedizinMainz and #HeartValveCenter closing the loop from interventional innovation to clinical reality, result of robust science and a fantastic newly assembled heart team.
@vonBardelebenRS, H. Treede, T. Goessler, Tobias Ruf
Sebastian Rosch retweeted
Short-term, PASCAL and MitraClip show similar effects on MV geometry. However, PASCAL may better preserve MV orifice area and shows lasting results with signs of LV reverse remodeling after a year. #AHAJournals @RoschSeb @PhilippLurz @NoackThilo ahajrnls.org/3sYLNdQ
Sebastian Rosch retweeted
In an ideal world every 💊 we prescribe prevents an event #NNT1
Not there yet, but we may have come closer
Now in @eBioMedicine how to identify optimal responders to spironolactone in HFpEF a🧵
@PhilippLurz @m_unterhuber @thiele_holger
sciencedirect.com/science/ar…
Sebastian Rosch retweeted
Single-center data suggests ultrasound–based renal denervation lowers BP and is well-tolerated up to 24 months after treatment. #AHAJournals @RoschSeb @kp_rommel @BlazekStephan @KP_Kresoja @A_Schoeber @mvonroeder @thiele_holger @PhilippLurz @FenglerKarl ahajrnls.org/45qi241
Sebastian Rosch retweeted
We are happy to share our recent publication from #LeipzigHeartCenter in #JAHA
“Short‐Term Effects of Different Transcatheter Edge‐to‐Edge Devices on Mitral Valve Geometry”
Great joint team work amongst interventional cardiologist, anesthesiologists, and cardiac surgeons – at Leipzig, Germany
Sebastian Rosch retweeted
Lancet and NEJM
💥 breaking news 💥
Aktuell auf dem #ESCCongress von @thiele_holger vorgestellt und im @lancet veröffentlicht:
Die ECLS-SHOCK-Studie:
▶️ KEIN Vorteil für VA-ECMO im infarktbedingten kardiogenen Schock 💥
Nun gilt es zu analysieren, wer von der Therapie ggf. doch profitiert.
